8-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

________________

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of Earliest Event Reported) – June 27, 2006

________________________

WEST PHARMACEUTICAL SERVICES, INC.

(Exact name of registrant as specified in its charter)

_____________________

Pennsylvania	1-8036	23-1210010
(State or other jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)
101 Gordon Drive, PO Box 645, Lionville, PA		19341-0645
(Address of principal executive offices)		(Zip Code)

(610) 594-3319

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or address, if changed since last report)

____________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

(b) On June 27, 2006, Dr. Tenley E. Albright, a director of West Pharmaceutical Services, Inc. (the “Company”), retired from the Company’s Board of Directors.

Item 9.01 Financial Statements and Exhibits

(c) Exhibits

Exhibit #	Description
99.1	West Pharmaceutical Services, Inc. Press Release, dated June 29, 2006

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

WEST PHARMACEUTICAL SERVICES, INC.

/s/ John R. Gailey III

John R. Gailey III

Vice President, General Counsel and Secretary

June 30, 2006

EXHIBIT INDEX

Exhibit #	Description
99.1	West Pharmaceutical Services, Inc. Press Release dated June 29, 2006.

EX-99

Contacts: West Pharmaceutical Services, Inc. Michael A. Anderson Vice President and Treasurer (610) 594-3345 Investors and Financial Media: Financial Dynamics Julie Huang/Theresa Kelleher (212) 850-5600 wst@fd-us.com

Exhibit 99.1

West Pharmaceutical Services Announces Retirement of Tenley E. Albright from Board of Directors

LIONVILLE, Pa., June 29, 2006 -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today the retirement of Tenley E. Albright, M.D., from its Board of Directors effective immediately. Dr. Albright, 70, has been a director of the Company since 1993 and she retired pursuant to the Company’s retirement policy for directors. At a dinner held in connection with its meeting in Boston, the Board thanked Dr. Albright for her exemplary service to the Company and to its shareholders.

Donald E. Morel, Jr., Ph.D., West’s chairman and Chief Executive Officer, said “Tenley has been a dedicated and diligent Director for more than ten years. During her time on West’s Board, she contributed significantly to our deliberations on a wide range of subject matters and leaves the Company with very bright prospects. I, along with her fellow Directors, and West’s employees worldwide, are deeply grateful for her service to the Company and wish her all the best in her many pursuits in the future.”

In connection with Dr. Albright’s retirement, the Company’s Board will be reduced from eleven members to ten.

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. is the world’s premier manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. The Company also provides products with application to the personal care, food and beverage markets. West’s customers include the world’s leading pharmaceutical, biotechnology, generic drug and medical device producers. Headquartered in Lionville, Pennsylvania, West Pharmaceutical Services supports its partners and customers from 50 locations throughout North America, South America, Europe, Mexico, Japan, Asia and Australia. For more information, visit West at http://www.westpharma.com.